EUVIMEDPoznaj EUVIMED
Open access · CC BY 4.0

Bi-directional metabolic reprogramming between cancer cells and T cells reshapes the anti-tumor immune response

Yajing Qiu, Yihan Xu, Xinyuan Ding, Congcong Zhao, Hongcheng Cheng, Guideng Li iD

PLOS Biology · 2025-07-14 · 23 (7) · e3003284

DOI: 10.1371/journal.pbio.3003284 ↗

At a glance

Journal article in PLOS Biology, published online on 2025-07-14. Written by Yajing Qiu and 5 co-authors. Institution: National Key Laboratory of Immunity and Inflammation, Suzhou Institute of Systems Medicine, Chinese Academy of Medical Sciences & Peking Union Medica…. Major MEDLINE topics: Neoplasms, T-Lymphocytes. Cited 28 times so far (Crossref); 196 references. The full text is freely available (open access, CC BY 4.0). Funded by: Noncommunicable Chronic Diseases-National Science and Technology Major Project, National Natural Science Foundation of China, Central Research Institute Fund of the Chinese Academy of Medical Sciences.

AbstraktSubjectsDane bibliograficzneCiteRelated studies

Abstract (original language)

Cancer cells and T cells engage in dynamic crosstalk within the tumor microenvironment (TME), shaping tumor progression and anti-tumor immunity. While cancer cells reprogram metabolism to support growth and immune evasion, T cells must adapt their metabolic states to maintain effector functions. Tumor-driven metabolic perturbations, such as nutrient depletion and accumulation of immunosuppressive metabolites, profoundly impair T cell function and fate. Conversely, metabolically reprogrammed T cells can modulate the TME and influence tumor growth. This reciprocal metabolic crosstalk represents both metabolic competition and intercellular communication, offering promising therapeutic targets.

Subjects

MeSH terms (MEDLINE)

NeoplasmsT-LymphocytesAnimalsHumansCell CommunicationCellular ReprogrammingMetabolic ReprogrammingTumor Microenvironment

Authors and institutions

  • National Key Laboratory of Immunity and Inflammation, Suzhou Institute of Systems Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College, Suzhou, Jiangsu, China.
  • Key Laboratory of Synthetic Biology Regulatory Elements, Suzhou Institute of Systems Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College, Suzhou, Jiangsu, China.
  • Department of Pharmacy, Medical Science University and Suzhou Technology China Innovation Center, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Gusu School of Nanjing Medical U…

ORCID profiles: Guideng Li

Funding

  • Noncommunicable Chronic Diseases-National Science and Technology Major Project
  • National Natural Science Foundation of China
  • Central Research Institute Fund of the Chinese Academy of Medical Sciences
  • Innovation Fund for Medical Sciences (CIFMS)
  • Gusu Innovation and Entrepreneurship Talent Program
  • Basic Research Program of Jiangsu
  • Non-profit Central Research Institute Fund of Chinese Academy of Medical Sciences
  • CAMS Innovation Fund for Medical Sciences

Cite

APA

Qiu, Y., Xu, Y., Ding, X., Zhao, C., Cheng, H., & Li, G. (2025). Bi-directional metabolic reprogramming between cancer cells and T cells reshapes the anti-tumor immune response. PLOS Biology, 23(7), e3003284. https://doi.org/10.1371/journal.pbio.3003284

Vancouver

Qiu Y, Xu Y, Ding X, Zhao C, Cheng H, Li G. Bi-directional metabolic reprogramming between cancer cells and T cells reshapes the anti-tumor immune response. PLOS Biology. 2025;23(7):e3003284. doi:10.1371/journal.pbio.3003284

BibTeX
@article{Qiu2025,
  author = {Qiu, Yajing and Xu, Yihan and Ding, Xinyuan and Zhao, Congcong and Cheng, Hongcheng and Li, Guideng},
  title = {Bi-directional metabolic reprogramming between cancer cells and T cells reshapes the anti-tumor immune response},
  journal = {PLOS Biology},
  year = {2025},
  volume = {23},
  number = {7},
  pages = {e3003284},
  doi = {10.1371/journal.pbio.3003284}
}
Start for free →